Literature DB >> 16344449

Retinal anastomosis to choroidal neovascularization: a bum rap for a difficult disease.

Neil M Bressler.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 16344449     DOI： 10.1001/archopht.123.12.1741

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN： 0003-9950


× No keyword cloud information.
  10 in total

1.  Long-term visual outcome and prognostic factors of Intravitreal anti-vascular endothelial growth factor treatment for retinal angiomatous proliferation.

Authors:  Han Joo Cho; Tae Gon Lee; Sang Youn Han; Hyoung Seok Kim; Jae Hui Kim; Jung Il Han; Young Ju Lew; Jong Woo Kim
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-04-01       Impact factor: 3.117

2.  [Intravitreal ranibizumab for the treatment of retinal angiomatous proliferation].

Authors:  J Maaß; D Sandner; E Matthé
Journal:  Ophthalmologe       Date:  2017-06       Impact factor: 1.059

3.  One-year results of bevacizumab intravitreal and posterior sub-Tenon injection of triamcinolone acetonide with reduced laser fluence photodynamic therapy for retinal angiomatous proliferation.

Authors:  Yukari Shirakata; Chieko Shiragami; Ayana Yamashita; Eri Nitta; Atsushi Fujiwara; Fumio Shiraga
Journal:  Jpn J Ophthalmol       Date:  2012-09-19       Impact factor: 2.447

4.  Two-year results of combined intravitreal anti-VEGF agents and photodynamic therapy for retinal angiomatous proliferation.

Authors:  Masaaki Saito; Tomohiro Iida; Mariko Kano
Journal:  Jpn J Ophthalmol       Date:  2012-12-04       Impact factor: 2.447

5.  Long-term visual and anatomical outcomes following anti-VEGF monotherapy for retinal angiomatous proliferation.

Authors:  Tarek S Hemeida; Pearse A Keane; Laurie Dustin; Srinivas R Sadda; Amani A Fawzi
Journal:  Br J Ophthalmol       Date:  2009-10-23       Impact factor: 4.638

6.  Ranibizumab in monotherapy and combined with photodynamic therapy for retinal angiomatous proliferation.

Authors:  Luis Arias; Francisco Gómez-Ulla; José M Ruiz-Moreno
Journal:  Clin Ophthalmol       Date:  2016-05-17

7.  One year results of intravitreal ranibizumab monotherapy for retinal angiomatous proliferation: a comparative analysis based on disease stages.

Authors:  Young Gun Park; Young-Jung Roh
Journal:  BMC Ophthalmol       Date:  2015-12-21       Impact factor: 2.209

Review 8.  Resistance to anti-VEGF therapy in neovascular age-related macular degeneration: a comprehensive review.

Authors:  Shiqi Yang; Jingke Zhao; Xiaodong Sun
Journal:  Drug Des Devel Ther       Date:  2016-06-02       Impact factor: 4.162

9.  Angiographic results of retinal-retinal anastomosis and retinal-choroidal anastomosis after treatments in eyes with retinal angiomatous proliferation.

Authors:  Masaaki Saito; Tomohiro Iida; Mariko Kano; Kanako Itagaki
Journal:  Clin Ophthalmol       Date:  2012-08-28

Review 10.  Resistance to antivascular endothelial growth factor treatment in age-related macular degeneration.

Authors:  Paris Tranos; Athanasios Vacalis; Solon Asteriadis; Stavrenia Koukoula; Athanasios Vachtsevanos; Georgia Perganta; Ilias Georgalas
Journal:  Drug Des Devel Ther       Date:  2013-06-17       Impact factor: 4.162
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.